One-year risk of serious infection in patients treated with certolizumab pegol as compared with other TNF inhibitors in a real-world setting: data from a national U.S. rheumatoid arthritis registry
在真实世界环境中,接受塞妥珠单抗聚乙二醇治疗的患者与接受其他TNF抑制剂治疗的患者相比,一年内发生严重感染的风险:来自美国国家类风湿性关节炎登记处的数据
期刊:Arthritis Research & Therapy
影响因子:4.6
doi:10.1186/s13075-017-1496-5
Harrold, Leslie R; Litman, Heather J; Saunders, Katherine C; Dandreo, Kimberly J; Gershenson, Bernice; Greenberg, Jeffrey D; Low, Robert; Stark, Jeffrey; Suruki, Robert; Jaganathan, Srihari; Kremer, Joel M; Yassine, Mohamed